Home> General Dentistry> Anaesthesia & Surgery> Antibiotic Ointment> GUIDOR® Periocline® 2 % Periodontal Dental Ointment
GUIDOR®  Periocline® 2 % Periodontal Dental Ointment
GUIDOR®  Periocline® 2 % Periodontal Dental Ointment
GUIDOR®  Periocline® 2 % Periodontal Dental Ointment
GUIDOR®  Periocline® 2 % Periodontal Dental Ointment
GUIDOR®  Periocline® 2 % Periodontal Dental Ointment

GUIDOR® Periocline® 2 % Periodontal Dental Ointment

  • Mfg. Code:GUIPE001
  • Brand:Sunstar
  • Expiry: >= 1 year
  • Color:-
  • Origin:Switzerland

Estimated Shipping by 6 working days

  • Mfg. Code:GUIPE001
  • Brand:Sunstar
  • Color:-
  • Origin:Switzerland
  • Description
  • Features
  • Packaging Details

This product need to be kept in refrigerated. Please do not purchase if clinic do not have a fridge. Thank you.

GUIDOR(R) Periocline(R) 2%, Dental Ointment (GUIDOR Periocline), contains a local therapeutic antibiotic agent which acts in the treatment of moderate to severe chronic adult periodontal disease. The active ingredient minocycline hydrochloride, is gradually released from the microsphere formulation in-situ after injection of the formulation into the gingival sulcus. Minocycline has a high affinity for the surface of the tooth and therefore remains in situ after release. Therefore, it provides a simple-to-apply, sustained release adjunctive treatment for periodontitis.


Store in a refrigerator (2-8 Degree Celcius)

  • Easy to Handle
  • Sustained Release Formulation
  • Proven Clinical Benefits


Role of antimicrobials

Scaling and root planning (SRP) is the gold standard regimen for periodontal disease. However, pharmacological treatment can help eliminate pathogens in deep pockets or furcations, where mechanical treatment may have been less efficient. Matesanz (2013) reported that “the subgingival application of an antimicrobial adjunctively to SRP demonstrated additional clinical benefits (especially in PPD reductions).“ (1)

Importance of sustained contact

According to Matesanz, “ it is important not only to select the therapeutic agent, but the resulting pharmacokinetic profile, mainly due to the vehicle utilized for its topical application” Moreover, “scientific evidence supports the adjunctive use of local antimicrobials to SRP in deep or recurrent periodontal sites, mostly when the vehicle has shown pharmacodynamic properties assuring the sustained release of the antimicrobial.”

GUIDOR Periocline (minocycline 2 %) with its special slow-release microsphere process used as an adjunct to mechanical debridement, ideally matches the requirements described.


1. Matesanz-Pérez P1, García-Gargallo M, Figuero E, Bascones-Martínez A, Sanz M, Herrera D., A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis, J Clin Periodontol. 2013 Mar; 40(3): 227-41.

Active ingredient: minocycline

GUIDOR Periocline contains the active ingredient minocycline at a concentration of 2%. Minocycline is one of a group of antibiotics called tetracyclines.


Localized action:

  • With targetted antimicrobial efficiency on (1,2):
    • Anaerobes: Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Eikenella corrodens, Aggregatibacter actinomycetemcomitans
    • Spirochetes: Treponema denticola
  • High concentrations in-situ, low systemic concentrations (3)
    • In a pharmacokinetic study, concentrations of minocycline in gingival crevicular fluid remained at clinical-effective levels for a minimum of three days following the administration of 0.05 g of gel (1 mg minocycline) into periodontal pockets.
    • Serum levels after subgingival administration and even after direct oral administration of 0.5 g of gel (10 mg minocycline) were only in the range of 0.1-0.2 µg/ml. These levels are much lower than the serum levels which would be associated with the normal oral dose of 100-200 mg/day minocycline used in systemic therapy.


Eudragit® process:

    • Periocline is a light yellow-coloured ointment. The exclusive process of micro encapsulation (Eudragit®) allows continuous, regular and slow release of the minocycline drug over several days.
    • Thanks to the specific technology of our Eudragit Process, the active ingredient minocycline hydrochloride is gradually released in situ from the microsphere formulation after application of the gel into the periodontal pocket. Moreover, minocycline has a high affinity for the surfaces of the tooth and therefore remains available in situ after release from the formulation. Therefore, GUIDORPeriocline provides a simple-to-apply, sustained release adjunctive treatment for periodontitis.




1. Satomi et al. Minocycline HCl concentration in periodontal pocket after administration of LS007. Journal of Japanese Society of Periodontology, 1987; 29(3) : 937-43

2. Mc Coll E, Patel K, Dahlen G, Tonetti M, Graziani F, Suvan J, Laurell L. Supportive periodontal therapy using mechanical instrumentation or 2 % minocycline gel : a 12 month randomized controlled, single masked pilot study. J Clin Periodontol. 2006 ; 33 : 141-50

3. SmPC

5 x 0.5g Syringes

Similar Dealers Price Shipping Total

Dealer - 000431

Estimated Delivery by 22nd Aug, 2022
FREE std. shipping